Fluvoxamine maleate 25 MG Oral Tablet — RxCUI 903887
RxNorm drug concept · Semantic clinical drug
RxCUI 903887
Semantic clinical drug · SCD
● Current RxNorm concept 14 FDA products
20 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI903887
Official nameFluvoxamine maleate 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped14
Package NDCs mapped20
Reported Medicaid activity (SDUD)302,719 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Fluvoxamine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question. Fluvoxamine is in the SSRI family, which includes many antidepressants, but for these products it's specifically approved to treat obsessive-compulsive disorder (OC...
- What exactly does fluvoxamine treat — I thought it was an antidepressant?
- Fluvoxamine isn't a quick fix — it takes time. Doses start low and are increased gradually over several weeks, and meaningful symptom relief with OCD can take a number of weeks aft...
- Nausea is one of the most common early side effects and often improves as your body adjusts. You may also notice drowsiness, sweating, shakiness, diarrhea, or decreased appetite. T...
🕸️ Concept Web — How Fluvoxamine maleate 25 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Fluvoxamine maleate 25 MG Oral Tablet
RxCUI 903887 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Fluvoxamine
42355IN -
Fluvoxamine maleate
203143PIN
-
Fluvoxamine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Fluvoxamine Oral Tablet
372256SCDF -
Fluvoxamine maleate Oral Tablet
2645653SCDFP -
Fluvoxamine Oral Product
1161460SCDG -
Fluvoxamine Pill
1161461SCDG -
Fluvoxamine maleate Oral Product
2660966SCDGP -
Fluvoxamine maleate Pill
2660194SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Fluvoxamine Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Fluvoxamine maleate 25 MG
903886SCDC
-
Fluvoxamine maleate 25 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Fluvoxamine maleate 25 MG
SCDC · 903886 -
Fluvoxamine Oral Tablet
SCDF · 372256 -
Fluvoxamine maleate Oral Tablet
SCDFP · 2645653 -
Fluvoxamine Oral Product
SCDG · 1161460 -
Fluvoxamine Pill
SCDG · 1161461 -
Fluvoxamine maleate Oral Product
SCDGP · 2660966 -
Fluvoxamine maleate Pill
SCDGP · 2660194
📦 FDA Products & Package NDCs
14 products · 20 package NDCs
20 package NDCs map to RxCUI 903887 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 60505-0164-01 | 100 TABLET in 1 BOTTLE (60505-0164-1) | Fluvoxamine Maleate | Apotex Corp | 2001-07-10 |
| 60505-0165-01 | 100 TABLET in 1 BOTTLE (60505-0165-1) | Fluvoxamine Maleate | Apotex Corp | 2001-07-10 |
| 60505-0166-01 | 100 TABLET in 1 BOTTLE (60505-0166-1) | Fluvoxamine Maleate | Apotex Corp | 2001-07-10 |
| 62135-0931-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62135-931-90) | Fluvoxamine Maleate | Chartwell RX, LLC | 2024-12-18 |
| 62135-0932-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-932-60) | Fluvoxamine Maleate | Chartwell RX, LLC | 2024-12-18 |
| 62135-0933-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62135-933-30) | Fluvoxamine Maleate | Chartwell RX, LLC | 2024-12-18 |
| 62559-0158-01 | 100 TABLET, COATED in 1 BOTTLE (62559-158-01) | fluvoxamine maleate | ANI Pharmaceuticals, Inc. | 2011-08-09 |
| 62559-0159-01 | 100 TABLET, COATED in 1 BOTTLE (62559-159-01) | fluvoxamine maleate | ANI Pharmaceuticals, Inc. | 2011-08-09 |
| 62559-0160-01 | 100 TABLET, COATED in 1 BOTTLE (62559-160-01) | fluvoxamine maleate | ANI Pharmaceuticals, Inc. | 2011-08-09 |
| 69452-0287-20 | 100 TABLET, FILM COATED in 1 BOTTLE (69452-287-20) | Fluvoxamine maleate | Bionpharma Inc. | 2024-05-23 |
| 69452-0288-20 | 100 TABLET in 1 BOTTLE (69452-288-20) | Fluvoxamine maleate | Bionpharma Inc. | 2024-05-23 |
| 69452-0288-30 | 500 TABLET in 1 BOTTLE (69452-288-30) | Fluvoxamine maleate | Bionpharma Inc. | 2025-02-07 |
| 69452-0288-32 | 1000 TABLET in 1 BOTTLE (69452-288-32) | Fluvoxamine maleate | Bionpharma Inc. | 2025-02-07 |
| 69452-0289-20 | 100 TABLET, FILM COATED in 1 BOTTLE (69452-289-20) | Fluvoxamine maleate | Bionpharma Inc. | 2024-05-23 |
| 69452-0454-20 | 100 TABLET in 1 BOTTLE (69452-454-20) | Fluvoxamine maleate | Bionpharma Inc. | 2025-02-07 |
| 69452-0454-30 | 500 TABLET in 1 BOTTLE (69452-454-30) | Fluvoxamine maleate | Bionpharma Inc. | 2025-02-07 |
| 69452-0454-32 | 1000 TABLET in 1 BOTTLE (69452-454-32) | Fluvoxamine maleate | Bionpharma Inc. | 2025-02-07 |
| 69452-0455-20 | 100 TABLET in 1 BOTTLE (69452-455-20) | Fluvoxamine maleate | Bionpharma Inc. | 2025-02-07 |
| 69452-0455-30 | 500 TABLET in 1 BOTTLE (69452-455-30) | Fluvoxamine maleate | Bionpharma Inc. | 2025-02-07 |
| 69452-0455-32 | 1000 TABLET in 1 BOTTLE (69452-455-32) | Fluvoxamine maleate | Bionpharma Inc. | 2025-02-07 |
Observed labelers:
Bionpharma Inc. (11) ·
ANI Pharmaceuticals, Inc. (3) ·
Apotex Corp (3) ·
Chartwell RX, LLC (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.